Chromotek
Stage
Acquired | AcquiredTotal Raised
$530KMissing: Chromotek's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Chromotek's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Chromotek
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Chromotek is included in 1 Expert Collection, including Advanced Materials.
Advanced Materials
1,282 items
Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.
Chromotek Patents
Chromotek has filed 3 patents.
The 3 most popular patent topics include:
- Biotechnology
- Molecular biology
- Protein methods
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/11/2019 | 8/24/2021 | Molecular biology, Proteins, Protein methods, Biotechnology, Transcription factors | Grant |
Application Date | 3/11/2019 |
|---|---|
Grant Date | 8/24/2021 |
Title | |
Related Topics | Molecular biology, Proteins, Protein methods, Biotechnology, Transcription factors |
Status | Grant |
Latest Chromotek News
Mar 31, 2023
Click2Contact The ChromoTek GFP-Trap provides fast and effective one-step immunoprecipitation of GFP-fusion proteins and their interacting factors from cell extracts or organelles. The product is produced in alpacas which possess heavy chain antibodies that are devoid of light chains and bind their antigen via a single variable domain (VHH), also known as a nanobody. These VHH domains have good binding properties and can be recombinantly expressed at a consistent high quality without batch-to-batch variation. GFP-Trap also displays high affinity to bind even low abundant proteins. ChromoTek nanobody-based reagents are thoroughly validated, recombinantly expressed and ready to use. Due to their size and single chain characteristic, they should provide a higher level of performance than conventional IgG antibodies in applications such as immunoprecipitation, immunofluorescence, live cell imaging, biosensor assays and protein purification. ChromoTek offers the GFP-Trap coupled to agarose beads, magnetic agarose beads or Dynabeads. For more information: https://www.ptglab.com/products/chromotek-nanobody-based-reagents/nano-traps/ .
Chromotek Frequently Asked Questions (FAQ)
Where is Chromotek's headquarters?
Chromotek's headquarters is located at Am Klopferspitz 19, Planegg-Martinsried.
What is Chromotek's latest funding round?
Chromotek's latest funding round is Acquired.
How much did Chromotek raise?
Chromotek raised a total of $530K.
Who are the investors of Chromotek?
Investors of Chromotek include Proteintech Group, High-Tech Grunderfonds and Bayern Kapital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.